Lymph Node Mapping Using Indocyanine Green Solution in Diagnosing Patients With Malignant Melanoma

Completed · Not applicable

Conditions studied: Recurrent Melanoma

In brief

This clinical trial compares and contrasts lymph node mapping using indocyanine green (IC-GREEN), isosulfan blue (ISB), and TSC and Lymphoscintigraphy with 99-technetium (99Tc) sulfur colloid (TSC). Study participants with malignant melanoma will undergo all 3 evaluations to assess the extent of the spread of the melanoma.

Key facts

Study ID

NCT01898403

Run by

Stanford University

People needed

50

Starts

2013-06-01

Expected to finish

2015-04-01

Last updated by the study team

2017-05-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Ability to understand and willingness to sign informed consent document
• Signed written informed consent
• Malignant melanoma (MM) undergoing sentinel lymph node biopsy (SNLB)
• 18 years of age or older
• Complete blood count (CBC) and metabolic panel within 6 months

You may not qualify if…

• History of hepatic or renal failure
• Allergy to iodine containing products
• Pregnant or may be pregnant
• Psychiatric or addictive disorders that in the opinion of the research team, may not be able to meet study requirements
• Undergoing dialysis

Where it is running

• Stanford University Hospitals and Clinics — Stanford, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.